Sunrest Lifescience Income Statement

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '25 Sep 30, 2025	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021
Revenue	520.34	334.13	294.83	246.42	268.88	169.49
Revenue Growth (YoY)	60.61%	13.33%	19.65%	-8.35%	58.64%	54.76%
Cost of Revenue	333.07	200.78	199.88	148.78	174.62	113.6
Gross Profit	187.28	133.36	94.95	97.65	94.25	55.89
Selling, General & Admin	60.56	50.07	39.69	33.28	26.62	24.87
Other Operating Expenses	81.02	53.05	46.18	35.03	56.52	28.27
Operating Expenses	149.24	104.08	86.84	69.61	83.74	53.57
Operating Income	38.04	29.28	8.11	28.03	10.51	2.32
Interest Expense	-8.91	-2.89	-0.65	-0.59	-0.23	-0.08
Interest & Investment Income	0.01	0.01	-	-	-	-
Other Non Operating Income (Expenses)	-0.17	-0.17	-1.53	-0	-	-0
EBT Excluding Unusual Items	28.98	26.23	5.93	27.44	10.28	2.24
Gain (Loss) on Sale of Assets	-	-	-	-	0.22	-
Pretax Income	28.98	26.23	5.93	27.44	10.5	2.24
Income Tax Expense	8.15	6.13	3.67	7.01	2.73	0.58
Earnings From Continuing Operations	20.83	20.11	2.26	20.43	7.77	1.66
Minority Interest in Earnings	-3.22	-0.05	-	-	-	-
Net Income	17.6	20.05	2.26	20.43	7.77	1.66
Net Income to Common	17.6	20.05	2.26	20.43	7.77	1.66
Net Income Growth	-	788.48%	-88.95%	162.91%	369.55%	349.73%
Shares Outstanding (Basic)	4	4	3	3	3	3
Shares Outstanding (Diluted)	4	4	3	3	3	3
Shares Change (YoY)	-	29.14%	10.77%	-	-	-
EPS (Basic)	4.10	4.67	0.68	6.81	2.59	0.55
EPS (Diluted)	4.10	4.67	0.68	6.81	2.59	0.55
EPS Growth	-	587.57%	-90.03%	162.93%	370.91%	348.37%
Free Cash Flow	-27.3	15.49	-148.05	11.41	-9.15	-0.09
Free Cash Flow Per Share	-6.36	3.61	-44.55	3.80	-3.05	-0.03
Gross Margin	35.99%	39.91%	32.20%	39.63%	35.05%	32.98%
Operating Margin	7.31%	8.76%	2.75%	11.38%	3.91%	1.37%
Profit Margin	3.38%	6.00%	0.77%	8.29%	2.89%	0.98%
Free Cash Flow Margin	-5.25%	4.64%	-50.21%	4.63%	-3.40%	-0.05%
EBITDA	45.69	30.23	9.09	29.33	11.11	2.75
EBITDA Margin	8.78%	9.05%	3.08%	11.90%	4.13%	1.62%
D&A For EBITDA	7.65	0.95	0.97	1.3	0.6	0.43
EBIT	38.04	29.28	8.11	28.03	10.51	2.32
EBIT Margin	7.31%	8.76%	2.75%	11.38%	3.91%	1.37%
Effective Tax Rate	28.13%	23.35%	61.92%	25.54%	26.01%	26.02%
Revenue as Reported	520.39	334.18	294.84	246.71	269.1	169.49

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.